74 related articles for article (PubMed ID: 15809504)
1. Membrane biocompatibility does not affect whole body protein metabolism during dialysis.
Veeneman JM; Kingma HA; Stellaard F; de Jong PE; Reijngoud DJ; Huisman RM
Blood Purif; 2005; 23(3):211-8. PubMed ID: 15809504
[TBL] [Abstract][Full Text] [Related]
2. Differences in bio-incompatibility among four biocompatible dialyzer membranes using in maintenance hemodialysis patients.
Zhang DL; Liu J; Cui WY; Ji DY; Zhang Y; Liu WH
Ren Fail; 2011; 33(7):682-91. PubMed ID: 21787159
[TBL] [Abstract][Full Text] [Related]
3. The impact of standard high-flux polysulfone versus novel high-flux polysulfone dialysis membranes on inflammatory markers: a randomized, single-blinded, controlled clinical trial.
Kerr PG; Sutherland WH; de Jong S; Vaithalingham I; Williams SM; Walker RJ
Am J Kidney Dis; 2007 Apr; 49(4):533-9. PubMed ID: 17386321
[TBL] [Abstract][Full Text] [Related]
4. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
[TBL] [Abstract][Full Text] [Related]
5. Biocompatibility of hemodialysis membranes: evaluation in an ovine model.
Burhop KE; Johnson RJ; Simpson J; Chenoweth DE; Borgia J
J Lab Clin Med; 1993 Feb; 121(2):276-93. PubMed ID: 8433041
[TBL] [Abstract][Full Text] [Related]
6. The influence of cuprophan and polysulfone membranes on dialyzer reusability and intradialytic complications.
Kadiri S; Kehinde Z; Arije A; Salako BL
Afr J Med Med Sci; 2001 Sep; 30(3):191-4. PubMed ID: 14510127
[TBL] [Abstract][Full Text] [Related]
7. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
Lovcić V; Kes P; Zeljko R; Kusec V
Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
[TBL] [Abstract][Full Text] [Related]
8. Protein intake during hemodialysis maintains a positive whole body protein balance in chronic hemodialysis patients.
Veeneman JM; Kingma HA; Boer TS; Stellaard F; De Jong PE; Reijngoud DJ; Huisman RM
Am J Physiol Endocrinol Metab; 2003 May; 284(5):E954-65. PubMed ID: 12540372
[TBL] [Abstract][Full Text] [Related]
9. Clinical characterization of Dicea a new cellulose membrane for haemodialysis.
Hoenich NA; Woffindin C; Cox PJ; Goldfinch M; Roberts SJ
Clin Nephrol; 1997 Oct; 48(4):253-9. PubMed ID: 9352161
[TBL] [Abstract][Full Text] [Related]
10. The role of dialyzer membrane flux in bio-incompatibility.
Davenport A
Hemodial Int; 2008 Oct; 12 Suppl 2():S29-33. PubMed ID: 18837767
[TBL] [Abstract][Full Text] [Related]
11. Biocompatibility and performance of a modified cellulosic and a synthetic high flux dialyzer. A randomized crossover comparison between cellulose triacetate and polysulphon.
Grooteman MP; Nubé MJ; van Limbeek J; van Houte AJ; Daha MR; van Geelen JA
ASAIO J; 1995; 41(2):215-20. PubMed ID: 7640431
[TBL] [Abstract][Full Text] [Related]
12. Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in japanese patients on chronic non-reuse hemodialysis: a prospective cohort study from the J-DOPPS II study.
Yokoyama H; Kawaguchi T; Wada T; Takahashi Y; Higashi T; Yamazaki S; Fukuhara S; Akiba T; Akizawa T; Asano Y; Kurokawa K; Saito A;
Nephron Clin Pract; 2008; 109(2):c100-8. PubMed ID: 18596379
[TBL] [Abstract][Full Text] [Related]
13. Changes of serum albumin and C-reactive protein are related to changes of interleukin-6 release by peripheral blood mononuclear cells in hemodialysis patients treated with different membranes.
Memoli B; Minutolo R; Bisesti V; Postiglione L; Conti A; Marzano L; Capuano A; Andreucci M; Balletta MM; Guida B; Tetta C;
Am J Kidney Dis; 2002 Feb; 39(2):266-73. PubMed ID: 11840366
[TBL] [Abstract][Full Text] [Related]
14. Effect of the hemodialysis membrane on the inflammatory reaction in vivo.
Schindler R; Boenisch O; Fischer C; Frei U
Clin Nephrol; 2000 Jun; 53(6):452-9. PubMed ID: 10879665
[TBL] [Abstract][Full Text] [Related]
15. In vivo assessment of intact parathyroid hormone adsorption by different dialysis membranes during hemodialysis.
Balducci A; Coen G; Manni M; Perruzza I; Fassino V; Sardella D; Grandi F
Artif Organs; 2004 Dec; 28(12):1067-75. PubMed ID: 15554934
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein in patients on chronic hemodialysis with different techniques and different membranes.
Panichi V; Rizza GM; Taccola D; Paoletti S; Mantuano E; Migliori M; Frangioni S; Filippi C; Carpi A
Biomed Pharmacother; 2006 Jan; 60(1):14-7. PubMed ID: 16330177
[TBL] [Abstract][Full Text] [Related]
17. Improvement of dialyzer compatibility by reduction of membrane surface area.
Schaefer RM; Rautenberg W; Neumann S; Heidland A; Hörl WH
Clin Nephrol; 1986; 26 Suppl 1():S35-8. PubMed ID: 3644705
[TBL] [Abstract][Full Text] [Related]
18. Effect of dialysis membrane biocompatibility on polymorphonuclear granulocyte activity in dialysis patients.
Banche G; Allizond V; Giacchino F; Mandras N; Roana J; Bonello F; Belardi P; Tullio V; Merlino C; Carlone N; Cuffini AM
Nephrol Dial Transplant; 2006 Dec; 21(12):3532-8. PubMed ID: 16935897
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
Germin Petrović D
Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
[TBL] [Abstract][Full Text] [Related]
20. The influence of dialyzer geometry on blood coagulation and biocompatibility.
Lins LE; Boberg U; Jacobson SH; Kjellstrand C; Ljungberg B; Skröder R
Clin Nephrol; 1993 Nov; 40(5):281-5. PubMed ID: 8281717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]